Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 6:56 PM
Ignite Modification Date: 2025-12-24 @ 6:56 PM
NCT ID: NCT02299557
Eligibility Criteria: Inclusion Criteria: * Signed written informed consent. * Male or female subjects 18 to 55 years of age; * Spinal Cord Injury that occurred at least 3 months from randomization day and less than 3 years from randomization day. * At least 4 unwanted/unexpected incontinent events/week Exclusion Criteria: * Known allergy to Oxymetazoline or silicone. * Pregnancy or lactation. * Active cardiovascular or cerebrovascular disease including unstable angina, myocardial infarction, transient ischemic attacks/stroke, clinically significant arrhythmia, congestive heart failure, or cardiac valve abnormalities; * Type 1 diabetes mellitus; * Insulin treated type 2 diabetes mellitus; * Renal insufficiency. * Liver insufficiency. * Malignant disease within 5 years of screening; * History of rectal surgery. * History of HIV, hepatitis B, hepatitis C. * Has upon physical examination a rectal deformation or signs of rectal disease such as fissure, bleeding hemorrhoids, fistula, infection or space occupying lesion. * Has used, in the last 1 week, drugs that may affect blood coagulation, such as Aspirin (at a dose above 500 mg/day), Warfarin, Sintrom, Enoxaparin, Nadroparin, Heparin, Clopidogrel, Ticlopidine. * Hypertension (blood pressure over 150/105 mm Hg in screening visit) * Unable to understand the use instruction, as judged by the investigator.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 55 Years
Study: NCT02299557
Study Brief:
Protocol Section: NCT02299557